Clover Health Investments (CLOV) Accounts Payables (2020 - 2026)

Clover Health Investments' Accounts Payables history runs 7 years deep, the most recent figure standing at $39.2 million for Q1 2026.

• Quarterly Accounts Payables rose 28.2% year-over-year to $39.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.2 million (up 28.2% YoY) and the FY2025 annual result came in at $36.2 million, up 4.77% from the prior year.
• Accounts Payables was $39.2 million for Q1 2026 at Clover Health Investments, up from $36.2 million in the prior quarter.
• Across five years, Accounts Payables topped out at $47.5 million in Q1 2023 and bottomed at $11.2 million in Q1 2022.
• A 5-year average of $32.9 million and a median of $34.6 million in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2023 — Accounts Payables jumped 323.68% — and 2024, when it tumbled 68.81%.
• Clover Health Investments' Accounts Payables stood at $32.4 million in 2022, then gained by 14.61% to $37.2 million in 2023, then decreased by 7.05% to $34.6 million in 2024, then grew by 4.77% to $36.2 million in 2025, then climbed by 8.17% to $39.2 million in 2026.
• Business Quant data shows CLOV's Accounts Payables at $39.2 million in Q1 2026, $36.2 million in Q4 2025, and $32.9 million in Q3 2025.